3Año·

Small first additional purchase, if it falls even lower, even more ...


If Motley Fool wants to go "all in", it would be stupid not to risk another ant as well


Closer

18.01
BioCryst Pharms logo
Comprado a 13,60 €
4 Comentarios

Imagen de perfil
First ant position , second NVIDIA has KUV 40 and apparently Biocryst has a unique selling proposition with its drug
Mostrar respuesta
Imagen de perfil
Since when does Motley Fool go "all in" anywhere?
Imagen de perfil
@Randal They had published something like this, have a look at @Sedo...
Imagen de perfil
@GymTonic This is simply advertising. It has nothing to do with the article.
1
Únase a la conversación